Pharmaceutical :: Biopharmaceutical infrastructure key to lower drug development costs
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by NIST.